Ultrastructural Changes of Caudate Nucleus in Mice Chronically Treated with Manganese

REFERENCES

• Bonilla E. El Manganeso y su Importancia Biomédica. Maracaíbo: Astro Data S.A, 1987
   Google Scholar
• Barbeau A. Manganese and extrapyramidal disorders. Neurotoxicology 1984;5: 13–36
   PubMed Web of Science ®Google Scholar
• Yin Z, Jiang H, Lee ES, et al. Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation. J Neurochem 2010;112: 1190–8
   PubMed Web of Science ®Google Scholar
• Schmitt C, Strazielle N, Richaud P, et al. Active transport at the blood–CSF barrier contributes to manganese influx into the brain. J Neurochem 2011;117: 747–56
   PubMed Web of Science ®Google Scholar
• Guilarte TR. Manganese neurotoxicity: New perspectives from behavioral, neuro imaging, and neuropathological studies in humans and non-human primates. Front Aging Neurosci 2013;5: 1–10
   PubMedGoogle Scholar
• Gavin CE, Gunter KK, Gunter TE. Manganese and calcium efflux kinetics in brain mitochondria. Relevance to manganese toxicity. Biochem J 1990;266: 329–34
   PubMed Web of Science ®Google Scholar
• Gunter KK, Aschner M, Miller LM, et al. Determining the oxidation states of manganese in NT2 cells and cultured astrocytes. Neurobiol Aging 2006;27: 1816–26
   PubMed Web of Science ®Google Scholar
• Gunter TE, Miller LM, Gavin CE, et al. Determination of the oxidation states of manganese in brain, liver, and heart mitochondria. J Neurochem 2004;88: 266–80
   PubMed Web of Science ®Google Scholar
• Donaldson J, MGregor D, LaBella F. Manganese neurotoxicity: A model for free radical mediated neurodegeneration?. Can J Physiol Pharmacol 1982;60: 1398–405
   PubMed Web of Science ®Google Scholar
• Farina M, Avila DS, Da Rocha JB, et al. Metals, oxidative stress and neurodegeneration: A focus on iron, manganese and mercury. Neurochem Int 2013;62: 575–94
   PubMed Web of Science ®Google Scholar
• Archibald PS, Tyree C. Manganese poisoning and the attack of trivalent manganese upon catecholamines. Arch Biochem Biophys 1987;256: 638–50
   PubMed Web of Science ®Google Scholar
• Sistrunk SC, Ross MK, Filipov NM. Direct effects of manganese compounds on dopamine and its metabolite Dopac: An in vitro study. Environ Toxicol Pharmacol 2007;23: 286–6
   PubMed Web of Science ®Google Scholar
• Rivera-Mancía S, Ríos C, Montes S. Manganese accumulation in the CNS and associated pathologies. Biometals 2011;24: 811–25
   PubMed Web of Science ®Google Scholar
• Brouillet EP, Shinobu L, McGarvey U, et al. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism. Exp Neurol 1993;120: 89–94
   PubMed Web of Science ®Google Scholar
• Hamai D, Bondy SC. Oxidative basis of manganese neurotoxicity. Ann N Y Acad Sci 2004;1012: 129–41
   PubMed Web of Science ®Google Scholar
• Hazell AS, Normandin L, Norenberg MD, et al. Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment. Neurosci Lett 2006;396: 167–71
   PubMed Web of Science ®Google Scholar
• Milatovic D, Yin Z, Gupta RC, et al. Manganese induces oxidative impairment in cultured rat astrocytes. Toxicol Sci 2007;98: 198–205
   PubMed Web of Science ®Google Scholar
• Rama Rao KVR, Reddy PVB, Hazell AS, et al. Manganese induces cell swelling in cultured astrocytes. Neurotoxicology 2007;28: 807–12
   PubMed Web of Science ®Google Scholar
• Reaney SH, Kwik-Uribe CL, Smith D. Manganese oxidation state and its implications for toxicity. Chem Res Toxicol 2002;15: 1119–26
   PubMed Web of Science ®Google Scholar
• Settivari R, Levora J, Nass R. The divalent metal transporter homologues SMF-1/2 mediate dopamine neuron sensitivity in Caenorhabditis elegans model of manganism and Parkinson disease. J Biol Chem 2009;284: 35758–68
   PubMed Web of Science ®Google Scholar
• Yin Z, Aschner JL, Dos Santos AP, et al. Mitochondrial-dependent manganese neurotoxicity in rat primary astrocyte cultures. Brain Res 2008;1203: 1–11
   PubMed Web of Science ®Google Scholar
• Bonilla E, Arrieta A, Castro F, et al. Manganese toxicity: Free aminoacids in striatum and olfactory bulbo of the mouse. Invest Clin 1994;35: 175–81
   PubMedGoogle Scholar
• Bonilla E. Flameless atomic absorption spectrophotometric determination of manganese in rat brain and other tissues. Clin Chem 1978;24: 471–4
   PubMed Web of Science ®Google Scholar
• Castejón OJ. Manual de técnicas básicas para microscopía electrónica. Maracaibo: Universidad del Zulia-Facultad de Medicina, 1975
   Google Scholar
• Villalobos V, Bonilla E, Castellano A, et al. Ultrastructural changes of the olfactory bulb in manganese-treated mice. Biocell 2009;33: 187–97
   PubMed Web of Science ®Google Scholar
• Hernández-Fonseca JP, Rincón J, Pedreañez A, et al. Structural and ultrastructural analysis of cerebral cortex, cerebellum, and hypothalamus from diabetic rats. Exp Diabetes Res 2009;2009: Article ID 329632
   Web of Science ®Google Scholar
• Castejón OJ. Electron microscopic study of central axons degeneration in traumatic human brain edema. J Submicrosc Cytol 1985;17: 703–18
   PubMedGoogle Scholar
• Long DM. Capillary ultrastructure and blood-brain barrier in human malignant brain tumors. J Neuroscience 1970;32: 127–43
   Google Scholar
• Shibata S. Ultrastructure of blood-brain barrier in human brain tumor. No-Shinkei-Geka 1989;20: 1135–47
   Google Scholar
• O’Donnell ME, Tran L, Lam TI, et al. Bumetanide inhibition of the blood–brain barrier Na–K–Cl cotransporter reduces edema formation in the rat middle cerebral artery occlusion model of stroke. J Cerebral Blood Flow Metabol 2004;24: 1046–56
   PubMed Web of Science ®Google Scholar
• Su G. Regulation of Na+–K+–Cl-cotransporter in primary astrocytes by dibutyryl cAMP and high [K+]o. Am J Physiol 2000;279: C1710–21
   Web of Science ®Google Scholar
• Yan Y, Dempsey RJ, Flemmer A, et al. Inhibition of Na–K–Cl-cotransporter during focal cerebral ischemia decreases edema and neuronal damage. Brain Res 2003;961: 22–31
   PubMed Web of Science ®Google Scholar
• Kim HD, Sun GY, Sun AY. Manganese transport and Na/K/Cl cotransport in PC-12 cells. Ann N Y Acad Sci 1993;679: 376–81
   PubMed Web of Science ®Google Scholar
• Guzik TJ, Marvar PJ, Czesnikiewicz-Guzik M. Perivascular adipose tissue as a messenger of the brain-vessel axis: Role in vascular inflammation and dysfunction. J Physiol Pharmacol 2007;58: 591–610
   PubMed Web of Science ®Google Scholar
• Xu J, Ling EA. Studies of the ultrastructure and permeability of the blood–brain barrier in the developing corpus callosum in postnatal rat brain using electron dense tracers. J Anat 1994;184: 227–37
   PubMed Web of Science ®Google Scholar
• Shukakidze AA, Lazriev I, Khetsuriani R, et al. Changes in the ultrastructure of neuroglia in some regions of the rat brain in manganese chloride poisoning. Morfologiia 2001;120: 35–41
   PubMedGoogle Scholar
• Artola A. Diabetes-, stress- and ageing-related changes in synaptic plasticity in hippocampus and neocortex – The same metaplastic process? Eur J Pharmacol 2008;585: 153–62
   PubMed Web of Science ®Google Scholar
• Grillo CA, Piroli GG, Wood GE, et al. Immunocytochemical analysis of synaptic proteins provides new insights into diabetes-mediated plasticity in the rat hippocampus. Neuroscience 2005;136: 477–86
   PubMed Web of Science ®Google Scholar
• Khalid M, Aoun RA, Mathews TA. Altered striatal dopamine release following a sub-acute exposure to manganese. J Neurosci Methods 2011;202: 182–91
   PubMed Web of Science ®Google Scholar
• Guilarte TR, Burton NC, McGlothan JL, et al. Impairment of nigrostriatal dopamine neuro transmission by manganese is mediated by pre-synaptic mechanism(s): Implications to manganese-induced parkinsonism. J Neurochem 2008;107: 1236–47
   PubMed Web of Science ®Google Scholar
• Guilarte TR. Manganese and Parkinson’s disease: A critical review and new findings. Environ Health Perspect 2010;118: 1071–80
   PubMed Web of Science ®Google Scholar
• Colosimo C, Guidi M. Parkinsonism due to ephedrone neurotoxicity: A case report. Eur J Neurol 2009;16: e114–15
   PubMed Web of Science ®Google Scholar
• Sanotsky Y, Lesyk R, Fedoryshyn L, et al. Manganic encephalopathy due to “ephedrone” abuse. Mov Disord 2007;22: 1337–43
   PubMed Web of Science ®Google Scholar
• Selikhova M, Fedoryshyn L, Matviyenko Y, et al. Parkinsonism and dystonia caused by illicit use of Ephedrone – A longitudinal study. Mov Disord 2008;23: 2224–31
   PubMed Web of Science ®Google Scholar
• Sikk K, Haldre S, Aquilonius SM, et al. Manganese-induced parkinsonism in methcathinone abusers: Biomarkers of exposure and follow up. Eur J Neurol 2013;20: 915–20
   PubMed Web of Science ®Google Scholar
• Gunter TE, Gerstner B, Lester T, et al. An analysis of the effects of Mn2+ on oxidative phosphorylation in liver, brain, and heart mitochondria using state 3 oxidative rate assays. Toxicol Appl Pharmacol 2010;249: 65–75
   PubMed Web of Science ®Google Scholar
• Xie H, Guan J, Borrelli LA, et al. Mitochondrial alterations near amyloid plaques in an Alzheimer's disease mouse model. J Neurosci 2013;33: 17042–51
   PubMed Web of Science ®Google Scholar
• Zhou J, Wang L, Ling S, et al. Expression changes of growth-associated protein-43 (GAP-43) and mitogenactivated protein kinase phosphatase-1 (MKP-1) and in hippocampus of streptozotocin-induced diabetic cognitive impairment rats. Exp Neurol 2007;206: 201–8
   PubMed Web of Science ®Google Scholar
• Volman V, Ng LJ. Computer modeling of mild axonal injury: Implications for axonal signal transmission. Neural Comput 2013;25: 2646–81
   PubMed Web of Science ®Google Scholar
• Kawashima R, Kojima H, Nakamura K, et al. Alterations in mRNA expression of myelin proteins in the sciatic nerves and brains of streptozotocin-induced diabetic rats. Neurochem Res 2007;32: 1002–10
   PubMed Web of Science ®Google Scholar
• Mastrocola R, Restivo F, Vercellinatto I, et al. Oxidative and nitrosative stress in brain mitochondria of diabetic rats. J Endocrinol 2005;187: 37–44
   PubMed Web of Science ®Google Scholar
• Teplinskaia LE, Lastrebova NE, Vetrov ID, et al. Immunologic autoaggression in patients with diabetic retinopathy under type I diabetes mellitus. Zh Mikrobiol Epidemiol Immunobiol 2006;7: 59–62
   PubMedGoogle Scholar
• Zochodne DW, Levy D. Nitric oxide in damage, disease and repair of the peripheral nervous system. Cell Mol Biol 2005;51: 255–67
   PubMed Web of Science ®Google Scholar